FDA 483 - Calmare Therapeutics, Inc. - May 22, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Calmare Therapeutics, Inc. in Shelton, CT, a specification developer for a Class II Scrambler Therapy MC-5A TENS device, revealed significant deficiencies in their quality system. The firm was cited for not establishing fundamental procedures for design control, quality audits, management review, MDRs, complaint handling, and corrective and preventive actions. Several of these observations were repeats from a previous inspection in 2017, indicating a persistent lack of compliance with essential regulatory requirements.
- Person
ID · 7735acd8-ba51-4fd1-9c26-432776b32d26